Supply & brands
Multi-origin sourcing, owned and licensed brands, regulated market access and distribution relationships across Europe.
BH Labs is the mother company connecting and directing regulated supply, brand ownership, patient access, clinical operations and proprietary group intelligence across its operating companies.
Medical cannabis is the group’s first vertical. Integrated healthcare is the long-term architecture.
AS FEATURED IN BUSINESS OF CANNABIS →BH Labs owns the group architecture: capital allocation, strategy, governance, market expansion and the intelligence connecting each operating company. The companies execute distinct regulated functions. The mother company makes them operate as one integrated healthcare group.
The strategic value is created by connecting the full chain inside one corporate architecture—from regulated supply to patient access, care and group-level intelligence.
Multi-origin sourcing, owned and licensed brands, regulated market access and distribution relationships across Europe.
Digital discovery, onboarding and telemedicine pathways designed around repeatable, measurable patient journeys.
Regulated import, release and wholesale supply into pharmacies and clinics across the United Kingdom.
A private operating layer connecting company data, decisions, workflows and execution across the BH Labs group.
Multi-origin sourcing · brands · regulated market access
Each company has a defined role. BH Labs connects their execution, economics, data and strategic direction at mother-company level.
The group’s commercial engine connecting regulated products, brand partners and pharmacy channels across active markets.
Two operating units under one patient platform — ZAZAMED UK, a digital clinic for specialist consultation and compliant prescribing, and ZAZAMED Deutschland, the telemedicine pathway for Germany’s regulated market.
The group’s UK wholesale business — importing, distributing and supplying regulated medical cannabis to pharmacies and clinics, backed by the group’s global cultivation network.
The proprietary operating architecture connecting company truth, workflows, decisions and performance. It is not offered externally.
Supply · brands · market access
The original map is back: click the supply origins, regulated corridors and operating markets to follow the physical network. Cyan lines show the information BH Labs receives from every flow.
Patient and commercial market → demand, pharmacies, sales and CAC to BH Labs
Every executive operates with a private, role-specific AI dashboard connected to the same group truth, company memory and decision infrastructure.
Founder, CEO & CRO · Architect of BH OS
BH Labs is built by an operator with a documented track record on both sides of the chain — supply infrastructure and international brands.
BH OS and BH Intelligence receive information from every group flow: supply, inventory, brands, patients, consultations, prescriptions, pharmacies, marketing, finance, communications and executive decisions.
Supply, brands, patient access and clinical capability are aligned under one mother-company strategy.
Multiple origins, regulated corridors and priority commercial markets create a foundation for disciplined expansion.
Role-specific dashboards give leadership a shared group truth, faster decision cycles and institutional company memory.
The value sits in the connections: companies, markets, patients, clinical operations, distribution and intelligence operating under one controlling architecture.
Medical cannabis is the first vertical — the hardest regulatory environment, and the proof the model works. The infrastructure is designed for every field of care that follows.
Full-chain medical cannabis operations across the UK and Germany, supplied by a global cultivation network.
BH OS deepens across every company — one intelligence layer running patients, supply, commerce and decisions.
The same infrastructure applied beyond cannabis — toward continuous, intelligent care for human health at large.
Independent coverage of the group, its companies and its thesis. For interviews, comment and media materials, use the media enquiry channel below.
On the group's consolidation thesis: why fragmented cannabis operators lose to integrated, intelligence-led healthcare companies — and how BH Labs is built as one.
READ THE ARTICLE →For corporate development, strategic relationships, regulated market expansion and investment dialogue.
lilian@greensuccess.io→Leave your details and a short note. Enquiries reach the group directly.
[REQUIRED BEFORE LAUNCH — complete every bracketed field. A German commercial website may not go live without this page.]
BH Labs Holdings Ltd
[REGISTERED ADDRESS]
[COUNTRY]
Vertreten durch / Represented by: [MANAGING DIRECTOR(S)]
Handelsregister / Company register: [REGISTER COURT + NUMBER]
USt-IdNr. / VAT ID: [VAT NUMBER]
E-Mail: lilian@greensuccess.io
[NAME, ADDRESS]
This website stores no personal data. The contact form does not transmit or store any information on this site — submitting it opens your own email application with a pre-addressed message. Your theme preference (dark/light) is stored locally in your browser only and is never transmitted.
The hosting provider may process technical access data (IP address, timestamp, requested resource) for the purpose of delivering and securing the website (Art. 6 (1)(f) GDPR). [CONFIRM HOSTING PROVIDER AND RETENTION PERIOD.]
All fonts used on this site are hosted on our own server and are loaded exclusively from this domain. No connection is made to Google Fonts or any other third-party font service, and no data is transmitted to third parties when fonts are loaded.
Under the GDPR you have the right to access, rectification, erasure, restriction of processing, data portability, and objection. Contact: lilian@greensuccess.io. You also have the right to lodge a complaint with a supervisory authority.